Anges Québec Capital
3 Place Ville Marie Bureau 12350, Suite 1-100, Montréal, Qc, H3B 0E7, Canada
Overview
Investment fund supporting angel investors in innovative startups.
Founded
2012
Deals · 12mo
0
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
AAVAA | Feb 2023Participated | $1 MSeed | |
Revelate | Jan 2022Participated | $20 MSeries A | |
Gray Oncology Solutions | Aug 2021Participated | $1 MOther Equity | |
My Intelligent Machines | Apr 2021Participated | $4 MSeed | |
Inversago Pharma | Sep 2020Participated | $38 MSeries B | |
Laflamme Aéro | Feb 2020Participated | $2 MOther Equity | |
Densitas | Jun 2019Participated | $11 MOther Equity | |
Feldan Therapeutics | Sep 2018Participated | $13 MSeries A | |
impak Finance | Aug 2018Participated | $1 MOther Equity | |
Inversago Pharma | Jul 2018Participated | $7 MSeries A | |
Polystyvert | Jun 2018Participated | $8 MOther Equity | |
GOrendezvous | Nov 2017Led | $0.76 MOther Equity | |
AAVAA | Feb 2023Participated | $1 MSeed | |
Revelate | Jan 2022Participated | $20 MSeries A | |
Gray Oncology Solutions | Aug 2021Participated | $1 MOther Equity | |
My Intelligent Machines | Apr 2021Participated | $4 MSeed | |
Inversago Pharma | Sep 2020Participated | $38 MSeries B | |
Laflamme Aéro | Feb 2020Participated | $2 MOther Equity | |
Densitas | Jun 2019Participated | $11 MOther Equity | |
Feldan Therapeutics | Sep 2018Participated | $13 MSeries A | |
impak Finance | Aug 2018Participated | $1 MOther Equity | |
Inversago Pharma | Jul 2018Participated | $7 MSeries A | |
Polystyvert | Jun 2018Participated | $8 MOther Equity | |
GOrendezvous | Nov 2017Led | $0.76 MOther Equity |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 3 |
| Series A | 1 | 4 |
| Series B | 0 | 1 |
| Other Equity | 2 | 10 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jul '15 | 1 |
| Aug '15 | 0 |
| Sep '15 | 0 |
| Oct '15 | 0 |
| Nov '15 | 1 |
| Dec '15 | 1 |
| Jan '16 | 0 |
| Feb '16 | 0 |
| Mar '16 | 0 |
| Apr '16 | 0 |
| May '16 | 1 |
| Jun '16 | 1 |
| Jul '16 | 1 |
| Aug '16 | 0 |
| Sep '16 | 1 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 1 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 2 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 1 |
| Jul '18 | 1 |
| Aug '18 | 1 |
| Sep '18 | 1 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 1 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 1 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 1 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 1 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 1 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 1 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 9 |
| Networks, Cloud & Communication | 5 |
| Data, Analytics & IT | 4 |
| Hardware & Robotics | 4 |
| Media & Entertainment | 4 |
| Clean Energy & Sustainability | 3 |
| Enterprise Software | 2 |
| Space & Frontier Tech | 2 |
| Consumer & Lifestyle | 2 |
| Manufacturing | 2 |
| AI & Machine Learning | 2 |
| Professional Services | 2 |
| AR/VR | 1 |
| Real Estate & Construction | 1 |
| Transportation & Logistics | 1 |
| Marketing & Advertising | 1 |
| Fintech | 1 |
| Gaming & eSports | 1 |
| Developer Tools | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 13 |
| $5M-$10M | 4 |
| $10M-$25M | 3 |
| $25M-$50M | 1 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Canada | 21 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Anges Québec | 11 |
| Investissement Québec | 4 |
| Real Ventures | 3 |
| TandemLaunch | 3 |
| AmorChem | 2 |
| Cycle Capital Management | 2 |
| Desjardins Capital | 2 |
| Fonds de solidarit FTQ | 2 |
| JDRF T1D Fund | 2 |
| MEDTEQ+ | 2 |
| Sustainable Development Technology Canada | 2 |
| Accel-Rx Health Sciences Accelerator | 1 |
| adMare BioInnovations | 1 |
| BDC | 1 |
| BDC Capital | 1 |
| CME Ventures | 1 |
| Databricks Ventures | 1 |
| Energy Foundry | 1 |
| Forbion | 1 |
| General Catalyst | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 3 | 14% |
| Participating | 18 | 86% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 3 | 100% |